Secondary amyloidosis in a needle phobic intra-venous drug user

Amyloid

Volumn 14, Issue 3, 2007, Pages 255-258

  Miranda, Benjamin H ^a,b   Connolly, John O ^a   Burns, Aine P ^a  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^b NONE   (United Kingdom)

Author keywords

Amyloid; Amyloidosis; Co infection; Development; Drugs; Epidemiology; Geography; HBV; HCV; Hepatitis; HIV; IVDU; Prevalence; Ulcer; Ulceration

Indexed keywords

ADULT; ANAMNESIS; ARTICLE; CASE REPORT; CHRONIC KIDNEY FAILURE; HEMODIALYSIS; HEPATITIS; HUMAN; INTRAVENOUS DRUG ABUSE; KIDNEY AMYLOIDOSIS; MALE; NEEDLE; PHOBIA; PRIORITY JOURNAL;

ADULT; AMYLOID; AMYLOIDOSIS; HEPACIVIRUS; HUMANS; KIDNEY; MALE; NEEDLES; PHOBIC DISORDERS; SUBSTANCE ABUSE, INTRAVENOUS;

EID: 34547916115     PISSN: 13506129     EISSN: 17442818     Source Type: Journal    
DOI: 10.1080/13506120701456293     Document Type: Article

References (14)

1. Paydas S. Report on 59 patients with renal amyloidosis. Int Urol Nephrol 1999;31(5):619-631.
2. Beji S, Kaaroud H, Ben Moussa F, Goucha R, Abderrahim E, El Younsi F, Ben Maiz H. Renal amyloidosis complicating the outcome of chronic inflammatory colitis. Presse Med 2004 Jul 31;33(13):862-865.
3. Jacob H, Charytan C, Rascoff JH, Golden R, Janis R. Amyloidosis secondary to drug abuse and chronic skin suppuration. Arch Intern Med 1978 Jul;138(7):1150-1151.
4. Meador KH, Sharon Z, Lewis EJ. Renal amyloidosis and subcutaneous drug abuse. Ann Intern Med 1979 Oct;91(4):565-567.
5. Menchel S, Cohen D, Gross E, Frangione B, Gallo G. AA protein-related renal amyloidosis in drug addicts. Am J Pathol 1983 Aug;112(2):195-199.
6. Osick LA, Lee TP, Pedemonte MB, Jacob L, Chauhan P, Navarro C, Comer GM. Hepatic amyloidosis in intravenous drug abusers and AIDS patients. J Hepatol 1993 Aug;19(1):79-84.
7. Tan AU Jr, Cohen AH, Levine BS. Renal amyloidosis in a drug abuser. J Am Soc Nephrol 1995 Mar;5(9):1653-1658.
8. Neugarten J, Gallo GR, Buxbaum J, Katz LA, Rubenstein J, Baldwin DS. Amyloidosis in subcutaneous heroin abusers ("skin poppers' amyloidosis"). Am J Med 1986 Oct;81(4):635-640.
9. Gillmore JD, Lovat LB, Persey MR, Pepys MB, Hawkins PN. Amyloid load and clinical outcome in AA amyloidosis in relation to circulating concentration of serum amyloid A protein. Lancet 2001 Jul 7;358(9275):24-29.
10. do Sameiro Faria M, Sampaio S, Faria V, Carvalho E. Nephropathy associated with heroin abuse in Caucasian patients. Nephrol Dial Transplant 2003 Nov;18(11):2308-2313.
11. Cheng JT, Anderson HL Jr, Markowitz GS, Appel GB, Pogue VA, D'Agati VD. Hepatitis C virus-associated glomerular disease in patients with human immunodeficiency virus coinfection. J Am Soc Nephrol 1999 Jul;10(7):1566-1574.
12. Connolly JO, Gillmore JD, Lachmann HJ, Davenport A, Hawkins PN, Woolfson RG. Renal AA, Secondary, Amyloidosis in Intravenous Drug Users, Centres of Nephrology and National Amyloidosis Centre, Royal Free and University College Medical School, London. By Discussion 2005.
13. McAdam KP, Anders RF, Aiken G, Takitaki FF. Secondary amyloidosis and the serum amyloid precursor in leprosy: geographical variation and association with leukocytosis. Int J Lepr Other Mycobact Dis 1977 Apr-Jun;45(2):150-157.
14. Dinc A, Erdem H, Rowczenio D, Simsek I, Pay S, Bahce M, Lachmann H. Autosomal dominant periodic fever with AA amyloidosis: tumor necrosis factor receptor-associated periodic syndrome (TRAPS) in a Turkish family. J Nephrol. 2005 Sep-Oct;18(5):626-629.